Organic Active Ingredients TRIZ Cases

A tazarotene topical composition in an oil-in-water emulsion vehicle treats acne and psoriasis with reduced skin irritation.

Madrasin derivatives modulate the immunopeptidome to increase antigenic peptide presentation on cancer cells.

Macrocyclic beta-turn peptidomimetics activate Trk receptors to increase mucin secretion, resolving dry eye symptoms without ocular pain side effects.

Selective positive allosteric modulators of strychnine-sensitive alpha 1-glycine receptors provide effective pain relief without opioid side effects.

Optically pure benzyl-4-chlorophenyl-C-glucoside derivatives inhibit glucose reabsorption via specific stereochemical binding.

Metabolizable prodrug compounds deliver active JAK inhibitors to resolve oral bioavailability limits in ruxolitinib treatments.

3-Phenyl-isoquinolinone derivatives inhibit PARP-1 enzyme activity through targeted molecular binding.

Solvent-free biodegradable microneedles deliver lipophilic drugs via colloidal particles, bypassing first-pass metabolism and skin barriers.

Avocado soybean unsaponifiables and lipoic acid reduce pro-inflammatory mediators while preserving bone healing mechanisms.

Novel cyclic compounds with specific aromatic heterocycles resolve D3/D2 selectivity issues to minimize side effects.

TMPRSS2 inhibitors target aberrant protease activity to arrest tumor growth and improve survival outcomes in non-small cell lung cancer patients.

Pyrazolo pyridone compounds resolve the trade-off between treatment effectiveness and inhibitor specificity by selectively targeting JAK isoforms.

Calcium hydroxyapatite particles suspended in hyaluronic acid gel resolve rapid biodegradation and insufficient collagen generation.

Thieno[3,2-d]pyrimidine derivatives overcome T315I mutation resistance by modifying chemical parameters to maintain binding affinity.

Nanoparticle formulations deliver siRNA agents to inhibit TGFβ and Cox-2 gene expression in skin cancer cells.

Pyrazolyl-triazolopyridine derivatives block DLK and LZK signaling pathways, preventing retinal ganglion cell death in neurodegenerative disorders.

Optimized pH and acidity parameters enable room-temperature storage for three years, eliminating cold-chain logistics.

Naphthyridine amides modulate M2 receptors to treat heart failure without side effects.

Novel chromenopyrazole derivatives selectively modulate the GPR55 receptor through targeted structural modifications.

Substituted pyrazole compounds inhibit casein kinase 1 delta and epsilon isoforms, addressing the lack of effective inhibitors for cellular growth regulation.

Reduced chlorin analogues resolve low singlet oxygen yield and dark toxicity by modifying the pyrrole ring structure to improve stability.

A hydrogel composition using micronized croscarmellose sodium and hyaluronic acid to achieve stable viscosupplementation.

Chemical Formula 1 compounds inhibit mTORC1 activity and cross the blood-brain barrier, addressing insufficient CNS penetration of existing inhibitors.

NRF2 modulators regulate primordial follicle maturation to prevent premature egg depletion and treat infertility.

Novel Urotensin-II receptor antagonists target specific physiological pathways to treat vascular hypertension and heart failure conditions.

Administering a polymer hydrogel boosts Akkermansia muciniphila abundance without live culture instability.

Dental pulp exosomes deliver microRNAs to suppress amyloid precursor protein expression.

Dicer-processed dsRNA agents reduce HIF-1α mRNA levels, resolving specificity issues in existing inhibitors.

Halobetasol propionate composition utilizes multiplexed molecular penetration enhancers to improve skin delivery.

Administering Hsp70 inducers elevates protein levels to upregulate ABCA1, resolving ineffective HDL formation in atherosclerosis.

Triazolopyridine compounds inhibit Mps-1 kinase to treat proliferative disorders.

Upregulating protective miRNAs in CAR-T cells overcomes immunosuppressive tumor environments and reduces cytokine release syndrome.

Covalent T7-EA-ROR1 conjugates stimulate innate immunity to inhibit tumor growth while sparing normal cells from traditional chemotherapy damage.

A hemostatic spray disperses chitosan particles coated with a salt layer to enhance electrostatic interactions.

Substituted N-heteroaryl bipyrrolidine carboxamides modulate H3 receptors, resolving specificity and efficacy bottlenecks in treating CNS disorders.

A novel indole carboxamide compound structure designed to inhibit TRPC6 channels.

High-purity galacto-oligosaccharides suppress inflammatory cytokines and myeloperoxidase activity while repairing intestinal mucosa damage in IBD models.

Antibodies block the IGFBP3-TMEM219 apoptotic pathway to preserve islet morphology and insulin production.

Replacing chloroform with dichloromethane eliminates hazardous solvent risks while preventing insoluble ferric hydroxide impurity formation.

Albiflorin stimulates endogenous probiotics through CB2 receptor agonism, restoring microbial balance without adverse reactions from exogenous supplements.

Dry gellan gum particles swell into a soft pudding-like gel upon water contact, eliminating swallowing difficulties for pediatric and elderly patients.

Substituted methanopyridoisoindolones modulate muscarinic receptors through targeted structural design.

Bifunctional compounds conjugate BTK inhibitors with E3 ligase ligands to recruit targeted proteins for degradation.

Polyethylene glycol linkers mask hydrophobicity to prevent aggregation, maintaining pharmacokinetic stability while increasing drug loading capacity.

Substituted pyrido[3,4-d]pyrimidin-4-one derivatives inhibit histone demethylase enzymes to treat cancer.

Indazole compounds inhibit the Wnt signaling pathway, reducing uncontrolled cellular proliferation in cancer and genetic disorders.